Cite
HARVARD Citation
Butt, A. et al. (2017). Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES. Alimentary pharmacology & therapeutics. 45 (1), pp. 150-159. [Online].